The collaboration will bring together GE Healthcare’s cardiac CT scanners and clinical applications with HeartFlow’s FFRct, a non-invasive technology that helps clinicians diagnose and treat CAD.
FFRct uses deep learning to analyze data from a patient’s coronary CT angiogram. The technology creates a personalized digital 3-D model of a patient’s coronary arteries, which simulates blood flow and blockages to determine the extent of the disease and provide actionable treatment insights.
GE Healthcare and HeartFlow’s initial agreement focuses on the U.S., however, the companies plan to expand their collaborative services to other markets in the future.
More articles on health IT:
Cerner CEO Neal Patterson, 67, dies from cancer complications
Children’s National Health System reaches HIMSS Analytics Stage 6
Microsoft CIO resigns amid company layoffs
